Ted Bosworth

1 week ago | medscape.com | Ted Bosworth

PHOENIX — The overlapping symptoms of menopause and multiple sclerosis (MS) in aging women may warrant hormone replacement therapy (HRT), says one expert, who argues that the potential benefits in easing the combined symptom burden outweigh the therapy’s modest risks.

3 weeks ago | medscape.com | Ted Bosworth

SAN DIEGO — Patients with obesity and diabetes are at a substantially reduced risk of having a recurrence of atrial fibrillation (AF) after ablation if they are taking a glucagon-like peptide 1 (GLP-1) receptor agonist vs another diabetes drug, according to an analysis of matched cohorts with 3 years of follow-up.

1 month ago | medscape.com | Ted Bosworth

CHICAGO — A new artificial intelligence (AI) model performed about as well as high-sensitivity troponin for the detection of non–ST-elevated myocardial infarction (NSTEMI) on an ECG, but better than clinicians.

1 month ago | medscape.com | Ted Bosworth

CHICAGO — For patients with advanced heart failure, an injection of autologous mononuclear cells into damaged myocardia missed the primary endpoint in the sham-controlled, randomized, blinded CardiAMP-HF trial, but there was a strong signal of benefit, supporting further assessment.

1 month ago | medscape.com | Ted Bosworth

ORLANDO, Florida — Two lasers developed specifically to target the sebaceous gland were cleared by the US Food and Drug Administration (FDA) for the treatment of acne vulgaris in 2022, but it is unclear whether there are meaningful clinical differences between them. The good news has been the relatively high rates of efficacy reported with both devices, but Fernanda H.